These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28146670)

  • 1. The Antigenicity of the Tumor Cell - Context Matters.
    Kristensen VN
    N Engl J Med; 2017 Feb; 376(5):491-493. PubMed ID: 28146670
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
    Strønen E; Toebes M; Kelderman S; van Buuren MM; Yang W; van Rooij N; Donia M; Böschen ML; Lund-Johansen F; Olweus J; Schumacher TN
    Science; 2016 Jun; 352(6291):1337-41. PubMed ID: 27198675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.
    Godet Y; Desfrançois J; Vignard V; Schadendorf D; Khammari A; Dreno B; Jotereau F; Labarrière N
    Eur J Immunol; 2010 Jun; 40(6):1786-94. PubMed ID: 20217862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoantigen landscape dynamics during human melanoma-T cell interactions.
    Verdegaal EM; de Miranda NF; Visser M; Harryvan T; van Buuren MM; Andersen RS; Hadrup SR; van der Minne CE; Schotte R; Spits H; Haanen JB; Kapiteijn EH; Schumacher TN; van der Burg SH
    Nature; 2016 Aug; 536(7614):91-5. PubMed ID: 27350335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNOTHERAPY. Outsourcing the immune response to cancer.
    Yadav M; Delamarre L
    Science; 2016 Jun; 352(6291):1275-6. PubMed ID: 27284181
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer immunotherapy using tumor antigen-reactive T cells.
    Choi BK; Kim SH; Kim YH; Kwon BS
    Immunotherapy; 2018 Mar; 10(3):235-245. PubMed ID: 29370726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.
    Kunert A; van Brakel M; van Steenbergen-Langeveld S; da Silva M; Coulie PG; Lamers C; Sleijfer S; Debets R
    J Immunol; 2016 Sep; 197(6):2541-52. PubMed ID: 27489285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.
    Feldman SA; Assadipour Y; Kriley I; Goff SL; Rosenberg SA
    Semin Oncol; 2015 Aug; 42(4):626-39. PubMed ID: 26320066
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the disease.
    Parmiani G
    Melanoma Res; 1993 Dec; 3(6):391-3. PubMed ID: 7909243
    [No Abstract]   [Full Text] [Related]  

  • 10. Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.
    Prickett TD; Crystal JS; Cohen CJ; Pasetto A; Parkhurst MR; Gartner JJ; Yao X; Wang R; Gros A; Li YF; El-Gamil M; Trebska-McGowan K; Rosenberg SA; Robbins PF
    Cancer Immunol Res; 2016 Aug; 4(8):669-78. PubMed ID: 27312342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is antigen specificity the key to efficient adoptive T-cell therapy?
    Labarriere N; Khammari A; Lang F; Dreno B
    Immunotherapy; 2011 Apr; 3(4):495-505. PubMed ID: 21463191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
    Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
    Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
    Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Waardenburg syndrome type 4 gene, SOX10, is a novel tumor-associated antigen identified in a patient with a dramatic response to immunotherapy.
    Khong HT; Rosenberg SA
    Cancer Res; 2002 Jun; 62(11):3020-3. PubMed ID: 12036907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumours with genetically enhanced T lymphocytes.
    Sadelain M; Rivière I; Brentjens R
    Nat Rev Cancer; 2003 Jan; 3(1):35-45. PubMed ID: 12509765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment.
    Straetemans T; Berrevoets C; Coccoris M; Treffers-Westerlaken E; Wijers R; Cole DK; Dardalhon V; Sewell AK; Taylor N; Verweij J; Debets R
    Mol Ther; 2015 Feb; 23(2):396-406. PubMed ID: 25363716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.
    Butterfield LH; Jilani SM; Chakraborty NG; Bui LA; Ribas A; Dissette VB; Lau R; Gamradt SC; Glaspy JA; McBride WH; Mukherji B; Economou JS
    J Immunol; 1998 Nov; 161(10):5607-13. PubMed ID: 9820539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
    Valmori D; Dutoit V; Liénard D; Rimoldi D; Pittet MJ; Champagne P; Ellefsen K; Sahin U; Speiser D; Lejeune F; Cerottini JC; Romero P
    Cancer Res; 2000 Aug; 60(16):4499-506. PubMed ID: 10969798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive cell therapy: Honing that killer instinct.
    Humphries C
    Nature; 2013 Dec; 504(7480):S13-5. PubMed ID: 24352359
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.
    Robbins PF; el-Gamil M; Kawakami Y; Stevens E; Yannelli JR; Rosenberg SA
    Cancer Res; 1994 Jun; 54(12):3124-6. PubMed ID: 8205528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.